UK launches national dementia registry BARBARA to link databases and speed clinical trials
BARBARA links around 180 existing dementia research databases into a single national platform.
BARBARA links around 180 existing dementia research databases into a single national platform.
MHRA approved Oxford's Ebola vaccine for phase one trials in 50 healthy UK adults, the first candidate to reach this stage after eight weeks of development.
More than £3 billion in public-private investment attracted to UK life sciences in the year after the 2025 Sector Plan launch.